Greater Glasgow and Clyde Medicines

NHS GGC Thromboprophylaxis Guidelines for COVID-19 patients are now available.

  Esmya (ulipristal acetate): suspension of the licence due to ri...

NHS GGC Guidance: Conversion from warfarin to a direct oral anticoagulant (DOAC) during hospital admission for patients with non-valvular atrial fibrillation* (AF) or venous thromboembolism (VTE) * non-valvular AF exclu...

Key messages: Following a review, the Commission on Human Medicines’ Expert Working Group on coronavirus (COVID-19) concluded that there is currently insufficient evidence to establish a link between use of...

COVID-19 NHSGGC Guidelines relating to medicines published between 13th and 17th April  New Adult NHSGGC Guidelines now available on StaffNet

The Adult Therapeutics Handbook content has now been updated. This update includes the publication of two new guidelines related to the COVID pandemic in the following section.

Key point Denosumab treatment for osteoporosis should continue during the current COVID-19 pandemic  Please refer to the following statement from the NHSGGC Osteoporosis Strategy Group: ...

Chloroquine and hydroxychloroquine are not licensed to treat COVID-19 related symptoms or prevent infection. Clinical trials are ongoing to test chloroquine and hydroxychloroquine as an agent in the treatment of COVID-1...

The Adult Therapeutics Handbook content has now been updated. This update includes the publication of two new guidelines related to the COVID pandemic in the following sections.